About High-grade neuroendocrine carcinoma of the corpus uteri
High-grade neuroendocrine carcinoma of the corpus uteri is a rare disease catalogued by Orphanet (ORPHA:213731). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to High-grade neuroendocrine carcinoma of the corpus uteri trials.
Search ClinicalTrials.gov for "High-grade neuroendocrine carcinoma of the corpus uteri" or Orphanet code ORPHA:213731 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting High-grade neuroendocrine carcinoma of the corpus uteri trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for High-grade neuroendocrine carcinoma of the corpus uteri. Updated daily.